Dual diagnosis psychosis and substance use disorders in adolescents part 2;Psychose und sucht bei jugendlichen und jungerwachsenen Teil 2: verlauf und behandlung

Fortschritte der Neurologie Psychiatrie

Volumn 78, Issue 2, 2010, Pages 90-100

  Meister, K ^a   Rietschel, L ^a   Burlon, M ^a   Gouzoulis Mayfrank, E ^b   Bock, T ^a   Lambert, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Clinical course; Dual diagnosis; Evidence based psychosocial treatments; Psychosis; Substance use disorder

Indexed keywords

ALCOHOL ABUSE; CANNABIS ADDICTION; COGNITIVE THERAPY; DISEASE COURSE; HUMAN; MOTIVATION; PATIENT CARE; PSYCHOSIS; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; REVIEW; SCHIZOPHRENIA; SUBSTANCE ABUSE;

ADOLESCENT; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; MENTAL DISORDERS; MOTIVATION; PSYCHOTHERAPY; PSYCHOTHERAPY, BRIEF; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SUBSTANCE-RELATED DISORDERS;

EID: 77049092055     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0028-1109979     Document Type: Review

References (152)

1. Lambert M, Conus P, Lubman D I., et al. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatrica Scandinavica 2005 112 141-148
2. Harrison I, Joyce E M., Mutsatsa S H., et al. Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study. Psychological Medicine 2008 38 79-88
3. Bartels S J., Drake R, Wallach W A. Long-term course of substance use disorders among patients with severe mental illness. Psychiatric Services 1995 46 248-251
4. Drake R E., McHugo G J., Xie H, et al. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders. Schizophrenia Bulletin 2006 32 464-473
5. Xie H, McHugo G J., Helmstetter B S., et al. Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders. Schizophrenia Research 2005 75 337-348
6. Drake R E., Wallach M A., McGovern M P. Future directions in preventing relapse to substance abuse among clients with severe mental illnesses. Psychiatric Services 2005 56 1297-1302
7. Hides L, Dawe S, Kavanagh D J., et al. Psychotic symptom and cannabis relapse in recent-onset psychosis. British Journal of Psychiatry 2006 189 137-143
8. Wade D, Harrigan S, Edwards J, et al. Course of substance misuse and daily tobacco use in first-episode psychosis. Schizophrenia Research 2006 81 145-150 (Pubitemid 43107688)
9. Addington J, Addington D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatrica Scandinavica 2007 115 304-309
10. Caspari D. Cannabis and schizophrenia: results of a follow-up study. European Archives of Psychiatry and Clinical Neuroscience 1999 249 45-49
11. Farrelly S, Harris M G., Henry L G., et al. Prevalence and correlates of comorbidity 8 years after a first psychotic episode. Acta Psychiatrica Scandinavica 2007 116 62-70
12. Westermeyer J. Comorbid schizophrenia and substance abuse: a review of epidemiology and course. American Journal on Addictions 2006 15 345 s-355
13. Westermeyer J, Schneekloth T. Course of substance abuse in patients with and without schizophrenia. American Journal on Addictions 1999 8 54-63
14. Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophrenia Research 1999 35 93-100
15. Linszen D H., Dingemans P M., Lenior M E. Cannabis use and the course of recent onset schizophrenic disorders. Archives of General Psychiatry 1994 51 273-279
16. Linszen D H., Dingemans P M., Nugter M A. Patient attributes and expressed emotion as risk factors for psychotic relapse. Schizophrenia Bulletin 1997 23 119-130
17. Haywood T W., Kravitz H M., Grossman L S., et al. Predicting the revolving door phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. American Journal of Psychiatry 1995 152 856-861
18. Wade D, Harrigan S, Whelan G, et al. The impact of substance use disorders on clinical outcome in first-episode psychosis. Schizophrenia Research 2004 67 172
19. Margolese H C., Negrete J C., Tempier R, et al. A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: Changes in psychiatric symptoms and substance use. Schizophrenia Research 2006 83 65-75
20. Talamo A, Centorrino F, Tondo L, et al. Comorbid substance-use in schizophrenia: relation to positive and negative symptoms. Schizophrenia Research 2006 86 251-255
21. Wade D, Harrigan S, McGorry P D., et al. Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis. Journal of Clinical Psychiatry 2007 68 767-774
22. Margolese H C., Malchy L, Negrete J C., et al. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophrenia Research 2004 67 157-166
23. Janssen B, Gaebel W, Haerter M, et al. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders. Psychopharmacology 2006 187 229-236
24. Hunt G E., Bergen J, Bashir M. Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophrenia Research 2002 54 253-264
25. Soyka M. Substance misuse, psychiatric disorder and violent and disturbed behaviour. British Journal of Psychiatry 2000 176 345-350
26. Regier D A., Farmer M E., Rae D S., et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Journal of the American Medical Association 1990 264 2511-2518
27. Goodman L A., Rosenberg S D., Mueser K T., et al. Physical and sexual assault history in women with serious mental illness: prevalence, correlates, treatment, and future research directions. Schizophrenia Bulletin 1997 23 685-696
28. Cohen L J., Test M A., Brown R J. Suicide and schizophrenia: data from a prospective community treatment study. American Journal of Psychiatry 1990 147 602-607
29. Gut-Fayand A, Dervaux A, Olie J P., et al. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Research 2001 102 65-72
30. Buhler B, Hambrecht M, Loffler W, et al. Precipitation and determination of the onset and course of schizophrenia by substance abuse a retrospective and prospective study of 232 population-based first illness episodes. Schizophrenia Research 2002 54 243-251
31. Mueser K T., Yarnold P R., Rosenberg S D. Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophrenia Bulletin 2000 26 179-192
32. Brunette M F., Mueser K T., Drake R E. A review of research on residential programs for people with severe mental illness and co-occuring substance use disorders. Drug and Alcohol Review 2004 23 471-481
33. Bartels S J., Teague G B., Drake R E. Substance abuse in schizophrenia: service utilization and costs. Journal of Nervous and Mental Disease 1993 181 227-232
34. Dickey B, Azeni H. Persons with dual diagnosis of substance abuse and major mental illness: their excess costs of psychiatric care. American Journal of Public Health 1996 86 973-977
35. Dixon L, Haas G H., Weiden P J., et al. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. American Journal of Psychiatry 1991 148 224-230
36. Arndt S, Tyrrell G, Flaum M, et al. Comorbidity of substance abuse and schizophrenia: the role of premorbid adjustment. Psychological Medicine 1992 22 379-388
37. Sevy S, Robinson D G., Holloway S. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatrica Scandinavica 2001 104 367-374
38. Larsen T K., Melle I, Auestad B, et al. Substance abuse in first-episode non-affective psychosis. Schizophrenia Research 2006 88 55-62
39. Penk W E., Flannery R B., Irvin E, et al. Characteristics of substance-abusing persons with schizophrenia: the paradox of the dually diagnosed. Journal of Addictive Diseases 2000 19 23-30
40. Tsuang M T., Simpson J C., Zronfonl Z. Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history. Archives of General Psychiatry 1982 38 141-147
41. Potvin S, Sephery A A., Stip E. A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychological Medicine 2006 36 431-440
42. Potvin S, Joyal C C., Pelletier J, et al. Contradictory cognitive capacities among substance-abusing patients with schizophrenia. Schizophrenia Research 2008 100 242-251
43. Schnell T, Koethe D, Daumann J, et al. The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology 2009 205 45-52
44. Joyal C C., Halli P, Lapierre D, et al. Drug abuse and/ or dependence and better neuropsychological performance in patients with schizophrenia. Schizophrenia Research 2003 63 297-299
45. Phillips P, Johnson S. How does drug and alcohol misuse develop among people with psychotic illness? A literature review. Social Psychiatry and Psychiatric Epidemiology 2001 36 269-276
46. Gouzoulis-Mayfrank E. Komorbidität Psychose und Sucht: Grundlagen und Praxis: Steinkopff Verlag 2007
47. Drake R E., Mueser K T., Brunette M F., et al. A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatric Rehabilitation Journal 2004 27 360-374
48. Drake R E., ONeal E L., Wallach M. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. Journal of Substance Abuse Treatment 2008 34 123-138
49. Ziedonis D M., Smelson D, Rosenthal R N., et al. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. Journal of Psychiatric Practice 2005 11 315-339
50. Mueser K T., Drake D, Sigmon S, et al. Psychosocial interventions for adults with severe mental illnesses and co-occurring substance use disorders: a review of specific interventions. Journal of Dual Diagnosis 2005 1 57-82
51. Ridgely M S., Goldman H H., Willenbring M. Barriers to the care of persons with dual diagnoses: organisational and financing issues. Schizophrenia Bulletin 1990 16 123-132
52. Osher F C., Drake R E. Reversing a history of unmet needs: approaches to care for persons with co-occurring addictive and mental disorders. American Journal of Orthopsychiatry 1996 66 4-11
53. Horn D H., Bux D A. A pilot test of motivational interviewing groups for dually diagnosed inpatients. Journal of Substance Abuse Treatment 2001 20 191-195
54. Ridgely M S. Creating integrated programs for severely mentally ill persons with substance disorders. New Directions for Mental Health Services 1991 50 29-41
55. Epstein J van, Barker P, Vorburger M, et al. Serious mental illness and its co-occurrence with substance use. Rockville Substance abuse and mental health services administration, office of applied studies 2004
56. Brunette M F., Mueser K T. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occuring substance use disorders. Journal of Clinical Psychiatry 2006 67 10-17
57. Cleary M, Hunt G E., Matheson S, et al. Psychosocial treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews 2008 CD001088
58. Osher F C., Kofoed L L. Treatment of patients with psychiatric and psychoactive substance use disorders. Hospital and Community Psychiatry 1989 40 1025-1030
59. McHugo G J., Drake R E., Burton H L., et al. A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. Journal of Nervous and Mental Disease 1995 183 762-767
60. Prochaska J O., DiClemente C C., Norcross J. In search of how people change. American Psychologist 1992 47 1101-1114
61. DiClemente C C., Nidecker M, Bellack A S. Motivation and the stages of change among individuals with severe mental illness and substance abuse disorders. Journal of Substance Abuse Treatment 2008 34 25-35
62. Dumaine M L. Meta-analysis of interventions with co-occurring disorders of severe mental illness and substance abuse: implications for social work practice. Research on Social Work Practice 2003 13 142-165
63. Donald M, Dower J, Kavanagh D J. Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials. Social Science and Medicine 2005 60 1371-1383
64. Carey K B., Purnine D M., Maisto S A., et al. Treating substance abuse in the context of severe and persistent mental illness: Clinicians perspectives. Journal of Substance Abuse Treatment 2000 19 189-198
65. Laker C J. How reliable is the current evidence looking at the efficacy of harm reduction and motivational interviewing interventions in the treatment of patients with a dual diagnosis? Journal of Psychiatric and Mental Health Nursing 2007 14 720-726
66. Tsuang J, Fong T W., Lesser I L. Psychosocial treatment of patients with schizophrenia and substance abuse disorders. Addictive Disorders & their Treatment 2006 5 53-66
67. Drake R E., Mercer-McFadden C, Mueser K T., et al. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin 1998 24 589-608
68. Gouzoulis-Mayfrank E. Doppeldiagnose Psychose und Sucht Grundlagen und Therapie. Zeitschrift für Kinder-und Jugendpsychiatrie und Psychotherapie 2008 36 245-253
69. Tiet Q Q., Mausbach B. Treatments for patients with dual diagnosis: a review. Alcoholism: Clinical and Experimental Research 2007 31 513-536
70. Cleary M, Hunt G E., Matheson S, et al. Psychosocial treatments for people with co-occurring severe mental illness and substance misuse: systematic review. Journal of Advanced Nursing 2009 65 238-258
71. Ley A, Jeffery D P., McLaren S, et al. Psychosocial treatment programs for people with both severe mental illness and substance misuse. The Cochrane Library 2000 3 1-37
72. McHugo G J., Drake R E., Teague G B., et al. Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services 1999 50 818-824
73. Essock S M., Mueser K T., Drake R E., et al. Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders. Psychiatric Services 2006 57 185-196
74. Tarrier N. Cognitive behaviour therapy for schizophrenia a review of development, evidence and implementation. Psychotherapy and Psychosomatics 2005 74 136-144
75. Jones C, Cormac I, Silveira da Mota Neto J I., et al. Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews 2004 CD000524
76. Pekkala E, Merinder L. Psychoeducation for schizophrenia. Cochrane Database of Systematic Reviews 2006
77. Copeland J, Swift W, Roffman R, et al. A randomized controlled trial of brief cognitive behavioral interventions for cannabis use disorder. Journal of Substance Abuse Treatment 2001 21 55-64
78. Bellack A S., DiClemente C C. Treating substance abuse among patients with schizophrenia. Psychiatric Services 1999 50 75-80
79. Bellack A S., Bennett M E., Gearon J S., et al. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry 2006 63 426-432
80. DAmelio R, Behrendt B, Wobrock T. Psychoedukation Schizophrenie und Sucht. Manual zur Leitung von Patienten-und Angehörigengruppen. München Elsevier/Urban & Fischer 2007
81. Burlon M, Huber C. Suchtstörungen im Kindes-und Jugendalter: Das Handbuch: Grundlagen und Praxis. Thomasius R, Schulte-Markwort M, Küstner U, et al Stuttgart Schattauer 2009 82-87
82. Ziedonis D M., Trudeau K. Motivation to quit using substances among individual with schizophrenia: implications for a motivation-based treatment model. Schizophrenia Bulletin 1997 23 229-238
83. Miller W R., Rollnick S. Motivational interviewing: preparing people for change. New York Guilford Press 2002 2nd ed
84. Burke B, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. Journal of Consulting and Clinical Psychology 2003 71 843-861
85. Hettema J, Steele J, Miller W R. Motivational interviewing. Annual Review of Clinical Psychology 2005 1 91-111
86. Chanut F, Brown T G., Dongier M. Motivational interviewing and clinical psychiatry. Canadian Journal of Psychiatry 2005 50 715-721
87. Rogers C R. Client-centered therapy: its current practice, implications, and theory. Boston (MA) Houghton Mifflin 1951
88. Festinger L A. A theory of cognitive dissonance. Stanford Standford University Press 1957
89. Carey K B., Leontieva L, Dimmock J, et al. Adapting motivational interventions for comorbid schizophrenia and alcohol use disorders. Clinical Psychology: Science and Practice 2007 14 39-57
90. Carey K B., Purnine D M., Maisto S A., et al. Enhancing readiness-to-change substance abuse in persons with schizophrenia. A four-session motivation-based intervention. Behaviour Modification 2001 25 331-384
91. Martino S, Carroll K, Kostas D, et al. Dual diagnosis motivational interviewing: A modification of motivational interviewing for substance-abusing patients with psychotic disorders. Journal of Substance Abuse Treatment 2002 23 297-308
92. Martino S. Contemplating the Use of Motivational Interviewing With Patients Who Have Schizophrenia and Substance Use Disorders. Clinical Psychology: Science and Practice 2007 14 58-63
93. Bechdolf A, Pohlmann B, Reck C, et al. Motivationsbehandlung bei Patienten mit der Doppeldiagnose Psychose und Sucht: Eine übersicht. Fortschr Neurol Psychiatr 2005 73 728-735
94. McHugo G J., Drake R E., Brunette M F., et al. Methodological issues in research on interventions for co-occurring disorders. Schizophrenia Bulletin 2006 32 655-665
95. Hulse G K., Tait R J. Six-month outcomes associated with a brief alcohol intervention for adult in-patients with psychiatric disorders. Drug and Alcohol Review 2002 21 105-112
96. Martino S, Carroll K M., Nich C, et al. A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders. Addiction 2006 101 1479-1492
97. Martino S, Carroll K M., OMalley S S., et al. Motivational interviewing with psychiatrically ill substance abusing patients. American Journal on Addictions 2000 9 88-91
98. Santa Ana E J., Wulfert E, Nietert P J. Efficacy of group motivational interviewing (GMI) for psychiatric inpatients with chemical dependence. Journal of Consulting and Clinical Psychology 2007 75 816-822
99. James W, Koh G, Spencer C, et al. Managing mental health & drug use. Perth, Western Australia Uniprint 2002
100. Gouzoulis-Mayfrank E. Komorbidität von Sucht und anderen psychischen Störungen Grundlagen und evidenzbasierte Therapie. Fortschr Neurol Psychiatr 2008 76 263-271
101. Warren J I., Stein J A., Grella C E. Role of social support and self-efficacy in treatment outcomes among clients with co-occurring disorders. Drug and Alcohol Dependence 2007 89 267-274
102. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998 352 609-613 (Pubitemid 28380142)
103. Swanson A J., Pantalon M V., Cohen K R. Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. Journal of Nervous and Mental Disease 1999 187 630-635
104. Baker A, Lewin T J., Reichler H, et al. Evaluation of a motivational interview for substance use within psychiatric in-patient services. Addiction 2002 97 1329-1337
105. Schmitz J M., Averill P, Sayre S, et al. Cognitive-behavioral treatment of bipolar disorder and substance abuse: a preliminary randomized study. Addictive Disorders & their Treatment 2002 1 17-24
106. Weiss R D., Griffin M L., Kolodziej M E., et al. A randomized trial of integrated group therapy versus group drug counseling for bipolar disorder and substance dependence. American Journal of Psychiatry 2007 164 100-107
107. Graeber D A., Moyers T B., Griffith G, et al. A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal 2003 39 189-202
108. Bradley A C., Baker A, Lewin T J. Group intervention for coexisting psychosis and substance use disorders in rural Australia: outcomes over 3 years. Australian and New Zealand Journal of Psychiatry 2007 41 501-508
109. James W, Preston N J., Koh G, et al. A group intervention which assists patients with dual diagnosis reduce their drug use: a randomised controlled trial. Psychological Medicine 2004 34 983-990
110. Kemp R, Harris A, Vurel E, et al. Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry 2007 15 490-493
111. Naeem F, Kingdon D, Turkington D. Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy 2005 34 207-215
112. Hjorthi J C, Fohlmann A, Larsen A, et al. Design paper: the CapOpus trial: A randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials 2008 9 42
113. Jadad A R., Moore R A., Carrol D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996 17 1-12
114. Boutron I, Moher D, Altman D G., et al. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Annals of internal medicine 2008 148 295-309 (Pubitemid 351665487)
115. Barrowclough C, Haddock G, Tarrier N, et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry 2001 158 1706-1713
116. Baker A, Bucci S, Lewin T J., et al. Cognitivebehavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial. British Journal of Psychiatry 2006 188 439-448
117. Baker A, Lee N K., Claire M, et al. Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction. Addiction 2005 100 367-378
118. Bland J M., Kerry S M. Trials randomised in clusters. British Medical Journal 1997 315 600
119. Edwards J, Elkins K, Hinton M, et al. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatrica Scandinavica 2006 114 109-117
120. Kavanagh D J., Young R, White A, et al. A brief motivational intervention for substance misuse in recent-onset psychosis. Drug and Alcohol Review 2004 23 151-155
121. Haddock G, Barrowclough C, Tarrier N, et al. Cognitivebehavioural therapy and motivational intervention for schizophrenia and substance misuse. British Journal of Psychiatry 2003 183 418-426
122. Altman D G., Schulz K F., Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Annals of Internal Medicine 2001 134 663-694 (Pubitemid 32322245)
123. Moher D, Schulz K F., Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Journal of the American Medical Association 2001 285 1987-1991 (Pubitemid 32366951)
124. Campbell M K., Elbourne D R., Altman D G. CONSORT statement: extension to cluster randomised trials. British Medical Journal 2004 328 702-708
125. Cuffel B J. Prevalence estimates of substance abuse in schizophrenia and their correlates. Journal of Nervous and Mental Disease 1992 180 589-592
126. Xie H, McHugo G M., Fox M B. Substance abuse relapse in a ten-year prospective follow-up of clients with co-occurring severe mental and substance use disorders. Psychiatric Services 2005 56 1282-1287
127. Rollins A L., ONeill S J., Davis K E. Substance abuse relapse and factors associated with relapse in an inner-city sample of patients with dual diagnoses. Psychiatric Services 2005 56 1274-1281
128. Bradizza C M., Stasiewicz P R. Qualitative analysis of high-risk drug and alcohol use situations among severely mentally ill substance abusers. Addictive Behaviors 2003 28 157-169
129. Salyers M, Becker D R., Drake R E. A ten-year follow-up of supported employment. Psychiatric Services 2004 55 302-308
130. Bradizza C M., Stasiewicz P R., Carey K B. High-risk alcohol and drug use situations among seriously mentally ill patients: a preliminary investigation. Addictive Behaviors 1998 23 555-560
131. Alverson H, Alverson M, Drake R E. Social patterns of substance use among people with dual diagnoses. Mental Health Services Research 2001 3 3-14
132. Bartels S J., Drake R E. Residential treatment for dual diagnosis. Journal of Nervous and Mental Disease 1996 184 379-381
133. Sorbara F, Liraud F, Assens F, et al. Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. European Psychiatry 2003 18 133-136
134. Coldham E L., Addingtin J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica 2002 106 286-290
135. Kamali M, Kelly L, Gervin M, et al. Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia. Psychiatric Services 2001 52 161-166
136. Soyka M, Albus M, Kathmann N. Prevalence of alcohol and drug abuse in schizophrenic inpatients. European Archives of Psychiatry and Clinical Neuroscience 1993 242 362-372
137. Verdoux H, Liraud P, Gonzales B, et al. Suicidality and substance misuse in first-admitted subjects with psychotic disorder. Acta Psychiatrica Scandinavica 1999 100 389-395
138. Lukoff D, Nuechterlein K H., Ventura J. Manual for expanded Brief Psychiatric Rating Scale (BPRS). Schizophrenia Bulletin 1986 12 594-602
139. Beck A T., Steer R A., Brown G K. Beck Depression Inventory: Second Edition Manual. Orlando, FL Harcourt Brace and Company 1996
140. Kay S R., Fiszbein A, Opler L A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987 13 261-276
141. Andreasen N C. Negative symptoms in schizophrenia. Archives of General Psychiatry 1982 39 784-788
142. Birchwood M, Smith J, Cochrane R, et al. The Social Functioning Scale: the development and validation of a scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry 1990 157 853-859
143. Goldman H H., Skodal A E., Lave T R. Revising axis V for DSM-IV: a review of measures of social functioning. American Journal of Psychiatry 1992 149 1148-1156
144. McLellan A T., Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 1992 9 199-213
145. Darke S, Hall W, Wodak A. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. British Journal of Addiction 1992 87 733-742
146. Mueser K T., Drake R E., Clark R E., et al. Evaluating substance abuse in persons with severe mental illness. Cambridge Human Services Research Institute 1995
147. Raistrick D, Bradshaw J, Tober G, et al. Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package. Addiction 1994 89 563-572
148. Wing J K., Babor T, Brugha T. SCAN. Schedules for clinical assessment in neuropsychiatry. Archives of General Psychiatry 1990 47 (6) 589-593
149. Saunders J B., Aasland O G., Babor T F., et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on early detection of persons with harmful alcohol consumption-II. Addiction 1993 88 791-804
150. Gossop M, Darke S, Griffiths P. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995 90 607-614
151. Rollnick S, Heather N, Gold R, et al. Development of a short readiness to change questionnaire for use in brief, opportunistic interventions among excessive drinkers. British Journal of Addiction 1992 87 743-754
152. McConnaughy E A., Prochaska J O., Velicer F. Stages of change in psychotherapy: measurement and sample profiles. Psychotherapy 1983 20 368-375